Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: J Cyst Fibros. 2021 Feb 8;20(6):965–971. doi: 10.1016/j.jcf.2021.01.011

Table 1.

Subject characteristics of those included in retrospective analyses comparing historic and enrollment sweat chloride values. Additional details of the GOAL and PROSPECT cohorts were previously published (13, 14).

Total N= 406 individuals with paired samples GOAL (Cohort 1: G551D/Other) (N=131) GOAL (Cohort 2: R117H/other) (N=59) GOAL (Cohort 3: Non-G551D Gating/other) (N=18) PROSPECT (F508del homozygous) (N= 139) PROSPECT (F508del heterozygous) (N= 59)

Female, N (%) 60 (45.8%) 21 (35.6%) 7 (38.9%) 76 (54.7%) 30 (50.8%)

Age (years) at Enrollment:
Mean (SD) 20.9 (10.41) 29.8 (19.97) 21.3 (10.83) 20.8 (10.24) 26.3 (12.62)
Min, Max 6.0,59.4 6.0,72.9 8.6,45.5 6.7,57.6 12.3,66.8

Age (years) at Historic SC:
Mean (SD) 4.7 (7.23) 15.9 (19.82) 7.1 (7.91) 1.9 (4.80) 6.9 (10.77)
Min, Max 0.0,42.6 0.0,69.0 0.1,25.0 0.0,33.7 0.0,45.6

Time (years) from Historic SC to Enrollment:
Mean (SD) 16.2 (9.26) 13.9 (12.37) 14.2 (8.64) 18.9 (9.28) 19.4 (10.17)
Min,Max 0.1,44.0 0.1,54.9 1.3,31.0 4.7,47.8 3.9,49.2

FEV1 % Predicted at Enrollment:
Mean (SD) 79.9 (24.78) 85.8 (20.65) 69.8 (23.03) 82.8 (24.12) 79.8 (25.13)
Min, Max 22.9,138.2 31.7,118.9 22.2,113.8 20.6,132.9 34.5,138.8